Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 28;11(5):977.
doi: 10.3390/nu11050977.

The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review

Gwendolyn N Y van Gorkom  1 , Eline L Lookermans  2 , Catharina H M J Van Elssen  3 , Gerard M J Bos  4
Affiliations

The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review

Gwendolyn N Y van Gorkom et al. Nutrients. .

Abstract

Many cancer patients on intensive chemotherapy lack vitamin C. Vitamin C stimulates the production and activation of immune cells, so perhaps supplementation could be used to improve the immunity in those patients. This review assesses the effectiveness and safety of vitamin C administration in cancer. The PubMed and EMBASE databases were searched and all study designs except for phase I studies, and case reports were included in this review. A total of 19 trials were included. In only 4 trials randomization was used to determine if patients received vitamin C or a placebo. The result of this review does not prove that there is a clinically relevant positive effect of vitamin C supplementation in cancer patients in general on the overall survival, clinical status, quality of life (QOL) and performance status (PS), since the quality of the studies published is low. Interventions and patient groups are very diverse, hence an effect in some patient groups is possible. There seems to be a better effect with intravenous than oral administration. Nevertheless, treatment with vitamin C is safe with minimal side effects. Thereby, we think it is safe to examine the effects of vitamin C on specific groups of patients in a randomized controlled setting.

Keywords: adverse events; ascorbic acid; cancer; overall survival; supplementation; vitamin C.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of the article selection.
Figure 2
Figure 2
Itemized Judgments for risk of bias based on “The Cochrane Collaboration’s tool for assessing risk of bias in randomized trials”. Risk is presented percentages across all included RCTs.
See this image and copyright information in PMC

References

    1. Cameron E., Pauling L. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc. Natl. Acad. Sci. USA. 1976;73:3685–3689. doi: 10.1073/pnas.73.10.3685. - DOI - PMC - PubMed
    1. Cameron E., Campbell A. The orthomolecular treatment of cancer. Ii. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem. Biol. Interact. 1974;9:285–315. doi: 10.1016/0009-2797(74)90019-2. - DOI - PubMed
    1. Creagan E.T., Moertel C.G., O’Fallon J.R., Schutt A.J., O’Connell M.J., Rubin J., Frytak S. Failure of high-dose vitamin c (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N. Engl. J. Med. 1979;301:687–690. doi: 10.1056/NEJM197909273011303. - DOI - PubMed
    1. Padayatty S.J., Sun H., Wang Y., Riordan H.D., Hewitt S.M., Katz A., Wesley R.A., Levine M. Vitamin c pharmacokinetics: Implications for oral and intravenous use. Ann. Intern. Med. 2004;140:533–537. doi: 10.7326/0003-4819-140-7-200404060-00010. - DOI - PubMed
    1. Chen Q., Espey M.G., Sun A.Y., Pooput C., Kirk K.L., Krishna M.C., Khosh D.B., Drisko J., Levine M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc. Natl. Acad. Sci. USA. 2008;105:11105–11109. doi: 10.1073/pnas.0804226105. - DOI - PMC - PubMed

Publication types